Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy.
Phosphomannose isomerase (PMI) deficiency is the cause of a new type of carbohydrate-deficient glycoprotein syndrome (CDGS). The disorder is caused by mutations in the PMI1 gene. The clinical phenotype is characterized by protein-losing enteropathy, while neurological manifestations prevailing in ot...
Na minha lista:
| Udgivet i: | J Clin Invest |
|---|---|
| Principais autores: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Clinical Investigation
1998
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC508719/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9525984/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI2350 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
